{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:48:31Z","timestamp":1794959311547,"version":"4.9.1"},"reference-count":18,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T00:00:00Z","timestamp":1729987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Tumori"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>There is debate about the optimal management of borderline resectable (bRe) and resectable (Re) pancreatic ductal adenocarcinoma (PDAC). Both preclinical and clinical evidence showed that carbon ion radiotherapy (CIRT) produces superior control on radioresistant histologies compared to conventional photon beam radiotherapy (RT). However, so far there is a lack of data concerning the integration of CIRT in a multimodal approach with chemotherapy and surgery for bRe\/Re.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We recently presented the first analysis of a multicenter prospective phase II clinical study aimed at assessing the feasibility and effectiveness of a neoadjuvant chemotherapy + short course of CIRT followed by surgery and adjuvant chemotherapy in the management of bRe\/Re PDAC. The study was terminated early due to low patient enrollment.Herein, we reported a post-hoc analysis focusing on toxicity, dosimetry and translational assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In our experience, CIRT can be integrated into a multimodal treatment strategy for bRe\/Re PDAC, alongside chemotherapy and surgery. A case of fatal liver failure occurring three months post-surgery has been documented, likely related to the combination approach. Although the treatment plans were satisfactory according to the Local Effect Model (LEM) model, recalculations using the modified Microdosimetric Kinetic Model (mMKM) revealed suboptimal target coverage. Additionally, we observed an increased expression of PD-L1 following CIRT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This multimodal approach was well tolerated; however, clinicians should carefully monitor for vascular disorders during follow-up and further investigate surgical techniques after CIRT. The increased PD-L1 expression supports the immunogenic effects of particle therapy and lays the groundwork for future studies. To enhance the therapeutic ratio of CIRT treatments, integrating LET-d based objectives into the plan optimization process should be considered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration Number:<\/jats:title>\n                    <jats:p>ClinicalTrials.gov Identifier: NCT03822936<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/03008916241291341","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:28:59Z","timestamp":1730075339000},"page":"470-474","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Preoperative chemo-CIRT in Re\/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (NCT03822936)"],"prefix":"10.1177","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1595-104X","authenticated-orcid":false,"given":"Amelia","family":"Barcellini","sequence":"first","affiliation":[{"name":"Radiation Oncology Unit, Clinical Department, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy"},{"name":"Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Molinelli","sequence":"additional","affiliation":[{"name":"Medical Physics Unit, Clinical Department, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Vanoli","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Unit of Anatomic Pathology, University of Pavia, Pavia, Italy"},{"name":"Unit of Anatomic Pathology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Vitolo","sequence":"additional","affiliation":[{"name":"Radiation Oncology Unit, Clinical Department, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Fossati","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, MedAustron Ion Therapy Center, Wiener Neustadt, Austria"},{"name":"Department for Basic and Translational Oncology and Haematology, Karl Landsteiner University of Health Sciences, Krems, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9020-5354","authenticated-orcid":false,"given":"Alessandro","family":"Vai","sequence":"additional","affiliation":[{"name":"Medical Physics Unit, Clinical Department, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pagani","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frediano","family":"Inzani","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Unit of Anatomic Pathology, University of Pavia, Pavia, Italy"},{"name":"Unit of Anatomic Pathology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Pecorilla","sequence":"additional","affiliation":[{"name":"Radiology Unit, Clinical Department, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Butturini","sequence":"additional","affiliation":[{"name":"Division of Hepato-Bilio-Pancreatic Surgery, P. Pederzoli Hospital, Peschiera del Garda, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Klersy","sequence":"additional","affiliation":[{"name":"Biostatistics & Clinical Trial Center, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Preda","sequence":"additional","affiliation":[{"name":"Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy"},{"name":"Radiology Institute, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Facoetti","sequence":"additional","affiliation":[{"name":"Radiobiology Unit, Research and Development Department, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Valvo","sequence":"additional","affiliation":[{"name":"Scientific Directorate, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6495-8574","authenticated-orcid":false,"given":"Ester","family":"Orlandi","sequence":"additional","affiliation":[{"name":"Radiation Oncology Unit, Clinical Department, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy"},{"name":"Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,10,27]]},"reference":[{"key":"bibr1-03008916241291341","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2016.11.010"},{"key":"bibr2-03008916241291341","unstructured":"NCCN Guidelines. Pancreatic Adenocarcinoma. Version 22023 n.d, https:\/\/www.nccn.org\/guidelines\/category_1 (accessed 13 November 2023)."},{"key":"bibr3-03008916241291341","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.08.009"},{"key":"bibr4-03008916241291341","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27723"},{"key":"bibr5-03008916241291341","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.06.2417"},{"key":"bibr6-03008916241291341","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6108-0"},{"key":"bibr7-03008916241291341","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2022.09.005"},{"key":"bibr8-03008916241291341","first-page":"19","volume":"21","author":"Hagiwara Y","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"bibr9-03008916241291341","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.12.021"},{"key":"bibr10-03008916241291341","doi-asserted-by":"publisher","DOI":"10.1667\/RR13904.1"},{"key":"bibr11-03008916241291341","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2015.08.014"},{"key":"bibr12-03008916241291341","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.09.041"},{"key":"bibr13-03008916241291341","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14246252"},{"key":"bibr14-03008916241291341","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08469-8"},{"key":"bibr15-03008916241291341","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs629"},{"key":"bibr16-03008916241291341","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2021.08.024"},{"key":"bibr17-03008916241291341","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S220971"},{"key":"bibr18-03008916241291341","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15102857"}],"container-title":["Tumori Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03008916241291341","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03008916241291341","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03008916241291341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:43:27Z","timestamp":1777661007000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03008916241291341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,27]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1177\/03008916241291341"],"URL":"https:\/\/doi.org\/10.1177\/03008916241291341","relation":{},"ISSN":["0300-8916","2038-2529"],"issn-type":[{"value":"0300-8916","type":"print"},{"value":"2038-2529","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,27]]}}}